Show Posts
|
Pages: [1]
|
AIOpinion is a neural network, which learns to detect most nosology types on various medical images. Those images are x-ray scans, ultrasound, computed tomography and magnetic resonance screening. Soon with AI Opinion application users can upload these images and send them for a remote diagnostics. Artificial intelligence will give the opinion on it and instructions of medical intervention necessity. AIOpinion application will be able to recognize more than 3000 of nosologies such as blood cells, lungs ultrasound, CT/MRI images of different body parts and many more. For AI Opinion this is only just a beginning. Our technologies will continue to develop.
|
|
|
The utilisation of the technology being created by AI Opinion is varied and wide. Its application can be applied in different markets and will benefit people the world over. However for investors we can identify three primary clients: patients, doctors and clinics. The mission that inspired the entire AI Opinion team was one of benevolent nature, primarily it is about saving lives. In developing a diagnostic service that is reliable, affordable and free to access they are going to be highly successful in doing just that. The patients are the focus and the biggest beneficiary of this new technology. Using AI Opinion people from all around the world will have access to diagnosis or a second opinion that could well just see something that everyone else had missed. Doctors will always consult with their peers and colleagues as much as possible to be sure they are giving a correct diagnosis. With AI Opinion they can quickly get a second opinion worth the mind of thousands of doctors, nurses and professionals with decades of experience in one. Clinics will not only benefit from the technology but help to refine it. With access to the wealth of data collected by AI Opinion they will also have the opportunity to upload and submit their own findings and analysis, helping the AI to learn and evolve further. It’s a technology that will continue to teach and learn, aiding research across the world. If you haven’t already help fund this fantastic project by investing in the blockchain today.
|
|
|
The birth of AI Opinion happened in 2016, or at least that was when the project was officially concepted. From there it has continued to grow, with over two years of experience already you now have the chance to invest in the blockchain and help the project evolve further. In the post we will give you a more in depth look at their journey so far. After conception the first task was preparation and the team began gathering medical scans, images and dates from institutions all around the world. In 2017 Q2 they began teaching the AI itself using these materials, medical professionals marked out which were the most pertinent and obvious for diagnosis. In Q1 of 2018 the project was officially announced and in Q2 they begin token sale allowing investors their first opportunity to get involved. The team is made up of men and women from all sectors but all with extensive experience in their relative fields. From seasoned tech heads on the development side to medical professionals who have spent their life saving lives; the team know precisely what they’re doing. They have come together with one mission in mind and that is to create a tool and a service that will benefit all those that use it.
|
|
|
AI Opinion are launching an ICO funding campaign. You can invest Cryptocurrency from the 1st of May into a Blockchain funding what is sure to be an industry changing technology. There are currently many diseases and ailments that are misdiagnosed or go undiagnosed completely, AI Opinion is a tool that provides an affordable and accurate third opinion. Since 2015 the team have been collecting data for analysis from leading medical institutions. The development continues and a firm roadmap has been laid out with milestones towards completion. In its current form the AI has been created and continues to learn and self-adjust. Only 10% of the necessary data has been uploaded and yet they have already reached a staggering level of 70% accuracy in cancer blood analysis. Going forward the plan is for the technology to grow, evolve and learn. It can provide medical professionals with support and users the world over with a valuable source of medical diagnosis. The funding obtained through the blockchain will primarily be used in the acquisition of new data for the AI to assimilate. The rest will be assigned to marketing and the AI development and implementation. From there the project will continue to grow, learn and expand within the industry.
|
|
|
|